Adamis Pharmaceuticals Corporation (ADMP)
Company Info
ISIN | US00547W2089 |
---|---|
CUSIP | 00547W208 |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Trading Data
Previous Close | $0.20 |
---|---|
Year Range | $0.13 - $0.67 |
EMA (50) | $0.19 |
EMA (200) | $0.32 |
Average Volume | $622.59K |
Market Capitalization | $29.76M |
ADMPShare Price Chart
Loading data...
ADMPPerformance
The chart shows the growth of $10,000 invested in Adamis Pharmaceuticals Corporation in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $368 for a total return of roughly -96.32%. All prices are adjusted for splits and dividends.
ADMPCompare to other instruments
ADMPReturns in periods
Period | Return | Benchmark |
---|---|---|
YTD | 17.65% | 5.75% |
1M | 25.00% | 5.61% |
6M | -44.44% | 0.92% |
1Y | -67.21% | -6.79% |
5Y | -44.85% | 7.18% |
10Y | -33.37% | 10.46% |
ADMPMonthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | -1.64% | 6.67% | -10.94% | -31.58% | 25.64% | 2.04% | -24.00% | -13.16% | -39.39% | -30.00% | 42.86% | -15.00% |
2021 | 137.06% | -2.61% | -16.07% | -15.96% | -12.66% | 59.42% | 7.27% | -7.63% | -11.01% | 8.25% | -21.90% | -25.61% |
2020 | -5.75% | -14.38% | -36.78% | 45.54% | -5.17% | 8.90% | 119.74% | -44.07% | 18.70% | -9.85% | -38.64% | 11.95% |
2019 | 36.44% | -3.58% | -28.72% | -2.84% | -26.34% | -13.91% | -11.54% | -18.35% | -24.97% | 14.98% | -28.06% | 20.20% |
2018 | -17.05% | -17.81% | 16.67% | 2.86% | 19.44% | -25.58% | 0.00% | -10.94% | 22.81% | -26.86% | 19.14% | -26.23% |
2017 | -1.59% | 11.29% | 23.19% | -12.94% | 4.05% | 35.06% | -11.54% | 18.48% | -4.13% | -0.48% | -26.92% | 15.79% |
2016 | -12.04% | 22.11% | 5.69% | 34.58% | 5.09% | -67.70% | 0.36% | 4.98% | 16.27% | -24.93% | 8.74% | 12.50% |
2015 | 10.53% | -5.87% | -38.63% | 9.14% | -0.70% | -1.64% | -0.24% | -12.65% | 5.74% | 11.63% | 5.32% | 18.68% |
2014 | 4.23% | -0.15% | -4.36% | -14.78% | 4.34% | -14.94% | -21.62% | 6.63% | 16.42% | 0.21% | -11.94% | 49.39% |
2013 | -4.23% | 16.18% | -16.46% | -24.24% | 49.80% | -11.88% | -22.73% | -19.61% | -8.54% | -6.67% | 12.86% | -4.84% |
2012 | -0.00% | 0.00% | 35.29% | 182.61% | 5.85% | 6.10% | -17.81% | -8.33% | 7.27% | 67.78% | -9.08% | -21.11% |
2011 | -2.33% | -14.29% | 3.33% | 23.66% | -4.35% | 0.00% | 4.55% | -15.22% | 7.69% | 14.29% | -4.17% | -26.09% |
2010 | 9.38% | 14.29% | -47.52% | -9.48% | -7.89% | 48.57% | 3.85% | -1.85% | -16.98% | 25.00% | -9.09% | -14.00% |
ADMPDividend History
Adamis Pharmaceuticals Corporation doesn't pay dividends
ADMPDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
ADMPWorst Drawdowns
The table below shows the maximum drawdowns of the Adamis Pharmaceuticals Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Adamis Pharmaceuticals Corporation is 99.27%, recorded on Oct 7, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-99.27% | Nov 9, 2012 | 2495 | Oct 7, 2022 | — | — | — |
-70.59% | Jan 14, 2010 | 533 | Feb 27, 2012 | 41 | Apr 25, 2012 | 574 |
-37.66% | Jun 20, 2012 | 58 | Sep 11, 2012 | 28 | Oct 19, 2012 | 86 |
-32.65% | May 2, 2012 | 7 | May 10, 2012 | 16 | Jun 4, 2012 | 23 |
-8.45% | Apr 30, 2012 | 1 | Apr 30, 2012 | 1 | May 1, 2012 | 2 |
-7.89% | Jun 6, 2012 | 2 | Jun 7, 2012 | 7 | Jun 18, 2012 | 9 |
-5% | Oct 26, 2012 | 1 | Oct 26, 2012 | 3 | Nov 2, 2012 | 4 |
-4.69% | Jan 5, 2010 | 1 | Jan 5, 2010 | 1 | Jan 6, 2010 | 2 |
-0.96% | Nov 5, 2012 | 1 | Nov 5, 2012 | 1 | Nov 6, 2012 | 2 |
ADMPVolatility Chart
Current Adamis Pharmaceuticals Corporation volatility is 64.82%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.